OPC Pharmaceutical JSC Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Net Sales

2,72,754.15

2,36,993.66

2,10,466.41

3,37,529.00

1,94,023.09

2,18,938.33

2,21,150.98

Other Operating Income

0.00

Total Operating income

2,72,754.15

2,36,993.66

2,10,466.41

3,37,529.00

1,94,023.09

2,18,938.33

2,21,150.98

Raw Material Cost

1,59,445.53

1,35,119.70

1,24,442.68

2,02,276.52

1,18,419.28

1,34,461.20

1,19,017.41

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

55,907.99

50,786.24

47,042.37

77,457.11

43,957.13

47,770.07

46,359.69

Power Cost

0.00

Manufacturing Expenses

4,004.61

0.00

1,758.46

0.00

798.12

80.97

Selling and Distribution Expenses

73,913.48

77,311.68

56,624.80

97,332.52

47,672.31

58,390.96

59,670.15

Other Expenses

-5,991.26

-5,078.62

-4,704.24

-7,921.56

-4,395.71

-4,856.82

-4,644.07

Total Expenditure (Excl Depreciation)

2,33,359.02

2,12,431.39

1,81,067.48

2,99,609.04

1,66,091.59

1,92,852.15

1,78,687.57

Operating Profit (PBDIT) excl Other Income

39395.100000000006

24562.3

29398.899999999998

37920

27931.5

26086.199999999997

42463.4

Other Income

5,946.63

3,635.49

1,213.53

2,528.73

614.88

8,458.06

-591.13

Operating Profit (PBDIT)

50,781.32

33,567.50

36,004.94

46,032.37

34,193.84

40,025.11

47,461.34

Interest

4,004.61

0.00

1,758.46

0.00

798.12

80.97

Exceptional Items

0.00

Gross Profit (PBDT)

1,13,308.62

1,01,873.96

86,023.73

1,35,252.47

75,603.81

84,477.13

1,02,133.57

Depreciation

5,439.55

5,369.74

5,392.47

5,583.69

5,647.46

5,480.88

5,589.06

Profit Before Tax

41,337.16

28,197.76

30,612.46

38,690.23

28,546.38

33,746.12

41,791.31

Tax

8,696.94

6,247.96

6,495.64

7,616.19

5,951.52

5,675.74

8,422.27

Provisions and contingencies

0.00

Profit After Tax

27,609.98

18,590.96

20,423.33

30,390.27

19,295.49

24,370.84

27,161.22

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

27,609.98

18,590.96

20,423.33

30,390.27

19,295.49

24,370.84

27,161.22

Share in Profit of Associates

0.00

Minority Interest

157.89

78.07

89.37

683.77

-103.22

398.80

1,414.66

Other related items

0.00

Consolidated Net Profit

27,767.87

18,669.04

20,512.70

31,074.04

19,192.27

24,769.64

28,575.89

Equity Capital

0.00

Face Value

10000.0

Reserves

8,79,858.90

8,47,376.58

8,27,482.40

8,12,208.19

7,83,791.50

7,61,107.55

8,39,101.91

Earnings per share (EPS)

431.06

290.25

318.86

474.47

301.25

380.49

424.06

Diluted Earnings per share

431.06

290.25

318.86

474.47

301.25

380.49

424.06

Operating Profit Margin (Excl OI)

14.44%

10.36%

13.97%

11.23%

14.4%

11.91%

19.2%

Gross Profit Margin

17.15%

14.16%

17.11%

13.12%

17.62%

17.92%

21.42%

PAT Margin

10.12%

7.84%

9.7%

9.0%

9.94%

11.13%

12.28%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is 15.09% vs 12.60% in Jun 2025

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2025 is 48.74% vs -8.99% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 49.79% vs -13.97% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of OPC Pharmaceutical JSC With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(VND)

Change(%)

Net Sales

2,72,754.15

6,92,879.69

-4,20,125.54

-60.63%

Other Operating Income

0.00

Total Operating income

2,72,754.15

6,92,879.69

-4,20,125.54

-60.63%

Raw Material Cost

1,59,445.53

6,40,730.17

-4,81,284.64

-75.12%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

55,907.99

0.00

55,907.99

Power Cost

0.00

Manufacturing Expenses

4,004.61

2,758.09

1,246.52

45.20%

Selling and Distribution Expenses

73,913.48

48,637.34

25,276.14

51.97%

Other Expenses

-5,991.26

-275.81

-5,715.45

-2,072.24%

Total Expenditure (Excl Depreciation)

2,33,359.02

6,89,367.51

-4,56,008.49

-66.15%

Operating Profit (PBDIT) excl Other Income

39,395.14

3,512.18

35,882.96

1,021.67%

Other Income

5,946.63

12,806.71

-6,860.08

-53.57%

Operating Profit (PBDIT)

50,781.32

16,318.88

34,462.44

211.18%

Interest

4,004.61

2,758.09

1,246.52

45.20%

Exceptional Items

0.00

Gross Profit (PBDT)

1,13,308.62

52,149.52

61,159.10

117.28%

Depreciation

5,439.55

0.00

5,439.55

Profit Before Tax

41,337.16

13,560.79

27,776.37

204.83%

Tax

8,696.94

3,364.49

5,332.45

158.49%

Provisions and contingencies

0.00

Profit After Tax

27,609.98

6,162.08

21,447.90

348.06%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

27,609.98

6,162.08

21,447.90

348.06%

Share in Profit of Associates

0.00

Minority Interest

157.89

4,034.22

-3,876.33

-96.09%

Other related items

0.00

Consolidated Net Profit

27,767.87

10,196.30

17,571.57

172.33%

Equity Capital

0.00

Face Value

10,000.00

0.00

Reserves

8,79,858.90

10,82,671.38

-2,02,812.48

-18.73%

Earnings per share (EPS)

431.06

0.00

431.06

Diluted Earnings per share

431.06

0.00

431.06

Operating Profit Margin (Excl OI)

14.44%

0.51%

0.00

13.93%

Gross Profit Margin

17.15%

1.96%

0.00

15.19%

PAT Margin

10.12%

0.89%

0.00

9.23%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 27,275.42 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is 15.09% vs 12.60% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 40.58% vs -12.79% in Sep 2024

Quarterly - Consolidate Net Profit

Consolidate Net Profit 2,776.79 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is 48.74% vs -8.99% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 44.68% vs 9.25% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 4,483.47 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is 49.79% vs -13.97% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 33.52% vs -25.42% in Sep 2024

Quarterly - Interest

Interest 400.46 Million

in Sep 2025

Figures in Million

QoQ Growth in quarter ended Sep 2025 is 0.00% vs 0.00% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 14.44%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024